{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:54:15Z","timestamp":1790042055330,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40618-020-01368-5","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T17:20:52Z","timestamp":1596129652000},"page":"745-753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1177-0516","authenticated-orcid":false,"given":"A.","family":"Avogaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Azzolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P.","family":"Fadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.amjcard.2017.05.014","volume":"120","author":"M Lehrke","year":"2017","unstructured":"Lehrke M, Marx N (2017) Diabetes mellitus and heart failure. Am J Cardiol 120:S37\u2013S47","journal-title":"Am J Cardiol"},{"key":"1368_CR2","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1161\/CIRCULATIONAHA.115.015511","volume":"132","author":"BM Scirica","year":"2015","unstructured":"Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P et al (2015) Response to letter regarding article, \u201cheart failure, Saxagliptin and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial\u201d. Circulation 132:e121\u2013e122","journal-title":"Circulation"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/eurheartj\/ehx511","volume":"39","author":"D Fitchett","year":"2018","unstructured":"Fitchett D, Butler J, van de Borne P, Zinman B, Lachin JM, Wanner C et al (2018) Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME(R) trial. Eur Heart J 39:363\u2013370","journal-title":"Eur Heart J"},{"issue":"5","key":"1368_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.118.034222","volume":"138","author":"K Radholm","year":"2018","unstructured":"Radholm K, Figtree G, Perkovic V, Solomon SD, Mahaffey KW, de Zeeuw D et al (2018) Canagliflozin and heart failure in type 2 diabetes mellitus: results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Circulation 138(5):458\u2013468","journal-title":"Circulation"},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED (2014) Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57:660\u2013671","journal-title":"Diabetologia"},{"key":"1368_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1007\/s00125-018-4700-5","volume":"61","author":"A Rosengren","year":"2018","unstructured":"Rosengren A, Edqvist J, Rawshani A, Sattar N, Franzen S, Adiels M et al (2018) Excess risk of hospitalisation for heart failure among people with type 2 diabetes. Diabetologia 61:2300\u20132309","journal-title":"Diabetologia"},{"key":"1368_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ejhf.1170","volume":"20","author":"PM Seferovic","year":"2018","unstructured":"Seferovic PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J et al (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20:853\u2013872","journal-title":"Eur J Heart Fail"},{"key":"1368_CR8","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00125-008-1164-z","volume":"51","author":"A Pazin-Filho","year":"2008","unstructured":"Pazin-Filho A, Kottgen A, Bertoni AG, Russell SD, Selvin E, Rosamond WD et al (2008) HbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 51:2197\u20132204","journal-title":"Diabetologia"},{"key":"1368_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","volume":"3","author":"A Dei Cas","year":"2015","unstructured":"Dei Cas A, Khan SS, Butler J, Mentz RJ, Bonow RO, Avogaro A et al (2015) Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail 3:136\u2013145","journal-title":"JACC Heart Fail"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.numecd.2013.03.008","volume":"23","author":"S Vigili de Kreutzenberg","year":"2013","unstructured":"Vigili de Kreutzenberg S, Avogaro A (2013) The limited clinical value of a specific diabetic cardiomyopathy. Nutr Metab Cardiovasc Dis 23:599\u2013605","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1368_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595\u2013602","journal-title":"Am J Cardiol"},{"key":"1368_CR12","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1093\/eurheartj\/ehm361","volume":"28","author":"E Konduracka","year":"2007","unstructured":"Konduracka E, Gackowski A, Rostoff P, Galicka-Latala D, Frasik W, Piwowarska W (2007) Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. Eur Heart J 28:2465\u20132471","journal-title":"Eur Heart J"},{"key":"1368_CR13","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339:b2535. https:\/\/doi.org\/10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"1368_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"1368_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.2044-8317.1988.tb00901.x","volume":"41","author":"BJ Becker","year":"1988","unstructured":"Becker BJ (1988) Synthesizing standardized mean-change measures. Br J Math Stat Psychol 41(2):257\u2013278","journal-title":"Br J Math Stat Psychol"},{"key":"1368_CR16","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/sim.1187","volume":"21","author":"SG Thompson","year":"2002","unstructured":"Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21:1559\u20131573","journal-title":"Stat Med"},{"issue":"24","key":"1368_CR17","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","volume":"138","author":"DA McAllister","year":"2018","unstructured":"McAllister DA, Read S, Kerssens J, Livingstone S, McGurnaghan S, Jhund P et al (2018) Incidence of hospitalisation for heart failure and case-fatality among 3.25 million people with and without diabetes. Circulation 138(24):2774\u20132786","journal-title":"Circulation"},{"key":"1368_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","volume":"392","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Sattar N, Franzen S, Rawshani A, Hattersley AT, Svensson AM et al (2018) Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 392:477\u2013486","journal-title":"Lancet"},{"key":"1368_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(15)00292-2","volume":"3","author":"A Rosengren","year":"2015","unstructured":"Rosengren A, Vestberg D, Svensson AM, Kosiborod M, Clements M, Rawshani A et al (2015) Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study. Lancet Diabetes Endocrinol 3:876\u2013885","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1368_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","volume":"262","author":"SC Larsson","year":"2018","unstructured":"Larsson SC, Wallin A, Hakansson N, Stackelberg O, Back M, Wolk A (2018) Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol 262:66\u201370","journal-title":"Int J Cardiol"},{"key":"1368_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","volume":"378","author":"M Lind","year":"2011","unstructured":"Lind M, Bounias I, Olsson M, Gudbjornsdottir S, Svensson AM, Rosengren A (2011) Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378:140\u2013146","journal-title":"Lancet"},{"key":"1368_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1464-5491.2005.01476.x","volume":"22","author":"O Torffvit","year":"2005","unstructured":"Torffvit O, Lovestam-Adrian M, Agardh E, Agardh CD (2005) Nephropathy, but not retinopathy, is associated with the development of heart disease in type 1 diabetes: a 12-year observation study of 462 patients. Diabet Med 22:723\u2013729","journal-title":"Diabet Med"},{"key":"1368_CR23","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.2337\/dc14-2100","volume":"38","author":"A Fagan","year":"2015","unstructured":"Fagan A, Asghar O, Pearce K, Stout M, Ray SG, Schmitt M et al (2015) Medalists with extreme duration of type 1 diabetes exhibit only mild diastolic dysfunction and myocardial fibrosis. Diabetes Care 38:e5\u20136","journal-title":"Diabetes Care"},{"key":"1368_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2337\/dc17-2364","volume":"41","author":"J Helve","year":"2018","unstructured":"Helve J, Sund R, Arffman M, Harjutsalo V, Groop PH, Gronhagen-Riska C et al (2018) Incidence of end-stage renal disease in patients with type 1 diabetes. Diabetes Care 41:434\u2013439","journal-title":"Diabetes Care"},{"key":"1368_CR25","doi-asserted-by":"publisher","first-page":"h4773","DOI":"10.1136\/bmj.h4773","volume":"351","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P (2015) Understanding the ecological fallacy. BMJ 351:h4773","journal-title":"BMJ"},{"key":"1368_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes C, Complications Trial \/Epidemiology of Diabetes I, Complications Study Research G","year":"2016","unstructured":"Diabetes C, Complications Trial \/Epidemiology of Diabetes I, Complications Study Research G (2016) Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care 39:686\u2013693","journal-title":"Diabetes Care"},{"key":"1368_CR27","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879\u20131884","journal-title":"Diabetes Care"},{"key":"1368_CR28","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/pedi.12633","volume":"19","author":"M Jaiswal","year":"2018","unstructured":"Jaiswal M, Divers J, Urbina EM, Dabelea D, Bell RA, Pettitt DJ et al (2018) Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Cohort Study. Pediatr Diabetes 19:680\u2013689","journal-title":"Pediatr Diabetes"},{"key":"1368_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijcard.2018.05.132","volume":"271","author":"G Lorenzoni","year":"2018","unstructured":"Lorenzoni G, Azzolina D, Lanera C, Brianti G, Gregori D, Vanuzzo D et al (2018) Time trends in first hospitalization for heart failure in a community-based population. Int J Cardiol 271:195\u2013199","journal-title":"Int J Cardiol"},{"issue":"1","key":"1368_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2018","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW (2018) Global trends in diabetes complications: a review of current evidence. Diabetologia 62(1):3\u201316","journal-title":"Diabetologia"},{"key":"1368_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jchf.2016.09.015","volume":"5","author":"IEM Bank","year":"2017","unstructured":"Bank IEM, Gijsberts CM, Teng TK, Benson L, Sim D, Yeo PSD et al (2017) Prevalence and clinical significance of diabetes in asian versus white patients with heart failure. JACC Heart Fail 5:14\u201324","journal-title":"JACC Heart Fail"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01368-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T23:30:17Z","timestamp":1627601417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01368-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]},"assertion":[{"value":"20 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}